Antihistamine Drugs Market Research Report - Forecast Till 2027

Antihistamine Drugs Market share, growth and trends analysis By Type (Sedating, Non-Sedating), Route of Administration (Oral Route, Parenteral Route, Rectal Route), Indication (Allergy, Urticaria, Dermatitis), End User (Hospitals, Clinics, Pharmaceutical Companies) - Forecast Till 2027

ID: MRFR/Pharma/2913-HCR | February 2021 | Region: Global | 206 pages

Antihistamine drugs Market Overview

Antihistamines are drugs mainly used for treating allergies. They are also used to treat motion sickness, insomnia and anxiety. They work by acting against a chemical called histamine which leads to many allergic symptoms. Antihistamines may cause side effects such as dizziness, dry mouth, nervousness, irritability, blurry vision and decreased appetite.


The antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and antihistamine drugs market is estimated to reach USD 280 million by 2023.


FIGURE 1 Global Antihistamine drugs Market by Region, 2016 (%)
Antihistamine Drugs Market


Key Players in the Antihistamine drugs Market   
     
                       
Some of the key players in antihistamine drugs market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)

Segments                                                                                                                                           

The antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.


On the basis of route of administration, the antihistamine drugs market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.


On the basis of indication, the antihistamine drugs market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the antihistamine drugs market is segmented into hospitals, clinics, pharmaceutical companies and others.

FIGURE 2 Research Methodology


Global Antihistamine Drugs Market


Regional Analysis of the Antihistamine drugs Market                 


The American region accounts for the largest share of the global market due to rising prevalence of allergy rhinitis and rising demand for diagnosis and treatment of allergic disease. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S.


Europe is the second largest market that holds a noticeable share of the antihistamine drugs market. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 50% of all Europeans will suffer from allergy in coming years.


In Asia Pacific, increase in the demand for drugs for the treatment of allergies and skin diseases drive the antihistamine drugs market growth. There has been a rise in the number of dermatology clinics across Asia Pacific from past few years. High rates of allergic rhinitis and increasing awareness regarding treatments available for allergy is poised to drive the growth of antihistamine drugs market in Asia Pacific.


The Middle East & Africa, the antihistamine drugs market shows steady but positive growth due to the rising prevalence of nasal allergies.


Intended Audience:



  • Antihistamine drug manufacturers

  • Antihistamine drug suppliers

  • Medical research laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2023: USD 280 Million
  • 2027: Significant Value
  •   CAGR   9.8% (2017-2023)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Route of Administration, Indication, End User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • High rates of allergic rhinitis
  • Increasing awareness regarding treatments available for allergy


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The Antihistamine Drug Market valuation would be USD 280 million.

    The players are Sanofi (France), Johnson & Johnson Consumer Inc. (U.S.), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), Bayer AG (Germany), and Prestige Brands Holdings, Inc. (U.S.).

    The types are sedating and non-sedating antihistamines.

    The types are allergy, urticaria, dermatitis, and others.

    Brief TOC

    1 Report Prologue

    2 Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    3 Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    4 Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    5. Market Factor Analysis

    5.1 Porters five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain

    5.3 Investment Feasibility Analysis

    5.4 Price Factor Analysis

    6 Global Antihistamine drugs Market, by Type

    6.1 Introduction

    6.2 Sedating Antihistamine Drugs

    6.2.1 Brompheniramine

    6.2.2 Chlorpheniramine

    6.2.3 Diphenhydramine

    6.2.4 Doxylamine

    6.2.5 Carbinoxamine

    6.2.6 Others

    6.3 Non-Sedating Antihistamine Drugs

    6.3.1 Fexofenadine

    6.3.2 Loratadine

    6.3.3 Loratadine ODT

    6.3.4 Others

    7 Global Antihistamine Drugs Market, By Route of Administration

    7.1 Introduction

    7.2 Oral Route

    7.3 Parenteral Route

    7.3.1 Intramuscular

    7.3.2 Subcutaneous

    7.3.3 Intravenous Route

    7.4 Rectal Route

    8 Global Antihistamine Drugs Market, by Indication

    8.1 Introduction

    8.2 Allergy

    8.3 Urticaria

    8.4 Dermatitis

    8.5 Others

    9 Global Antihistamine Drugs Market by End User

    9.1 Introduction

    9.2 Hospitals

    9.3 Clinics

    9.4 Pharmaceutical Companies

    9.5 Others

    10 Global Antihistamine Drugs Market by Region

    10.1 Introduction

    10.2 Americas

    10.2.1 North America

    10.2.1.1 U.S.

    10.2.1.2 Canada

    10.2.2 Latin America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 UK

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Republic of Korea

    10.4.5 Australia

    10.4.6 Rest of Asia Pacific

    10.5 Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of Middle East & Africa

    11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    12 Company Profiles

    12.1 Johnson & Johnson Consumer Inc.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 Sanofi

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Bayer AG

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Pfizer

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Merck Sharp & Dohme Corp.

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial Overview

    12.5.4 Key Developments

    12.6 Prestige Brands Holdings, Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 CVS Pharmacy

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical Industry

    14 Appendix